Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Thivolet

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Health Technology Assessments In Oncology: Crizotinib Case StudyM Thivolet, A Kornfeld, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Time Limits Restriction in GermanyM Thivolet, I Soussi, A Kornfeld, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Comparison of Additional Benefit Scores in Germany (Gba) and France (Has)I Soussi, M Thivolet, A Kornfeld, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
External Reference Pricing Impact of the Integration of the Amnog Discount In The List PriceM Thivolet, L Cetinsoy, A L Vataire, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Health Technology Assessments In Oncology: Crizotinib Case StudyM Thivolet, A Kornfeld, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Time Limits Restriction in GermanyM Thivolet, I Soussi, A Kornfeld, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Comparison of Additional Benefit Scores in Germany (Gba) and France (Has)I Soussi, M Thivolet, A Kornfeld, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
External Reference Pricing Impact of the Integration of the Amnog Discount In The List PriceM Thivolet, L Cetinsoy, A L Vataire, et al.
Pageof 1